OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
239
Results
Show all
Save search
Copy query
Show results for
Unknown
(227)
Proteomics
(11)
Genomics
(1)
Organisms
Homo sapiens
(7)
Morganella
(1)
Morganella
(1)
Pseudomonas sp.
(1)
Rattus norvegicus
(1)
Staphylococcus aureus
(1)
Staphylococcus aureus subsp. aureus NCTC 8325
(1)
Repository
pride
(9)
MassIVE
(2)
EGA
(1)
Tissue
Cell culture
(2)
Urine
(2)
Aortic valve
(1)
Hepatocyte
(1)
Sputum
(1)
Valve cell
(1)
Disease
Bladder disease
(1)
Cardiovascular system disease
(1)
Cystic fibrosis
(1)
Schizophrenia
(1)
Technology Type
Mass Spectrometry
(9)
Shotgun proteomics
(7)
Affinity purification coupled with mass spectrometry proteomics
(3)
Bottom-up proteomics
(1)
Data-independent acquisition
(1)
Instrument Platform
LTQ Orbitrap Velos
(1)
Q Exactive
(1)
Publication Date
2017
(2)
2016
(2)
2021
(2)
2026
(1)
2024
(1)
2022
(1)
2019
(1)
2015
(1)
Release Date
2022
(32)
2020
(27)
2021
(25)
2023
(21)
2025
(17)
2024
(17)
2019
(16)
2018
(15)
2017
(8)
2016
(8)
2015
(8)
2011
(6)
2013
(5)
2026
(4)
2014
(4)
2010
(4)
2007
(3)
2012
(2)
2009
(2)
2008
(1)
2006
(1)
2001
(1)
Lab affiliation
Brigham and Women's Hospital, Harvard Medical School
(1)
Center for Integrated Protein Science at the Department of Chemistry, Technische Universität München, Garching b. München 85747, Germany; Chair of Organic Chemistry II, Technische Universität München, Garching b. München 85747, Germany
(1)
Department of Chemistry, Johns Hopkins University
(1)
Department of Microbiology and Immunology Lineberger Cancer Center University of North Carolina, Chapel Hill
(1)
J. Craig Venter Institute, Rockville MD 20850 USA
(1)
J. Craig Venter Institute, Rockville, MD 20850
(1)
Technische Universität München Department of Chemistry Lehrstuhl Organische Chemie II Lichtenbergstr. 4 85747 Garching (bei München)
(1)
University of Greifswald, Institue for Microbiology
(1)
University of Greifswald, Institute of Microbiology, Department of Microbial Physiology & Molecular Biology
(1)
Previous
page
1 / 24
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
24
Next
page
Sort
by:
Relevance
Page size
10
On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease.
Not available
S-EPMC9633227
|
biostudies-literature
Cite
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.
Not available
S-EPMC5085020
|
biostudies-literature
Cite
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).
Not available
S-EPMC5850192
|
biostudies-literature
Cite
Visualization of autoantibodies and neutrophils in vivo identifies novel checkpoints in autoantibody-induced tissue injury.
Not available
S-EPMC7066238
|
biostudies-literature
Cite
Impact of patient selection in clinical trials: application of ROCKET AF and ARISTOTLE criteria in GARFIELD-AF.
Not available
S-EPMC11217994
|
biostudies-literature
Cite
Protein signatures from blood plasma and urine suggest changes in vascular function and IL-12 signaling in elderly with a history of chronic diseases compared with an age-matched healthy cohort.
Not available
S-EPMC8110643
|
biostudies-literature
Cite
4-sulfomuconolactone hydrolases from Hydrogenophaga intermedia S1 and Agrobacterium radiobacter S2.
Not available
S-EPMC2045233
|
biostudies-literature
Cite
Emulation of ARISTOTLE and ROCKET AF trials in real-world atrial fibrillation patients results in similar efficacy and safety as original landmark trials: insights from the GARFIELD-AF registry.
Not available
S-EPMC11751782
|
biostudies-literature
Cite
Safety outcomes of direct oral anticoagulants in older adults with atrial fibrillation: a systematic review and meta-analysis of (subgroup analyses from) randomized controlled trials.
Not available
S-EPMC10828375
|
biostudies-literature
Cite
Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials.
Not available
S-EPMC6370494
|
biostudies-literature
Cite
Previous
page
1 / 24
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
24
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
